Hypertension and ace gene insertion/deletion polymorphism in pediatric renal transplant patients

Pediatric Transplantation

Volumn 9, Issue 5, 2005, Pages 612-617

  Serdaroglu, Erkin ^a,b   Mir, Sevgi ^a   Berdeli, Afig ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Ambulatory blood pressure; HT; I D polymorphism of the ACE; Renal transplantation

Indexed keywords

CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORIMETRY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE REGRESSION; RISK FACTOR;

BLOOD PRESSURE MONITORING, AMBULATORY; CHILD; FEMALE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 26244439285     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00353.x     Document Type: Article

References (30)

1. BALUARTE JH, ALAN GB, INGELFINGER JR, STABLEIN D, TEJANI A. Analysis of hypertension in children post renal transplantation - a report of North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Nephrol 1994: 8: 570-573.
2. OPELZ G, WUJCIAK T, RITZ E. Collaborative Transplant Study. Association of chronic kidney greft failure with recipient blood pressure. Kidney Int 1998: 53: 217-222.
3. COLZALARI A, GIARDANO U, MATTEUCCI MC, et al. Hypertension in young patients after renal transplantation: ambulatory blood pressure versus casual blood pressure. Am J Hypertens 1998: 11: 497-501.
4. MATTEUCCI MC, GIORDANO U, CALZOLARI A, TURCHETTA A, SANTILLI A, RIZZONI G. Left ventricular hypertrophy, treadmill tests and 24-hour blood pressure in pediatric transplant patients. Kidney Int 1999: 56: 1566-1570.
5. ALPERT BS, DANIELS SR. Twenty-four hour ambulatory blood pressure monitoring: now that technology has come of age we need to catch up. J Pediatr 1997: 130: 167-169.
6. STAESSEN JA, WANG JG, GINOCCHIO G, et al. The deletion/insertion polymorphism of angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997: 15: 1579-1592.
7. JULVE R, CHAVES FJ, ROVIRA E, et al. Polymorphism insertion/deletion of the ACE gene and ambulatory blood pressure circadian variability in essential hypertension. Blood Press Monit 2001: 6: 27-32.
8. PARVING HH, JACOBSEN P, TARNOW L, et al. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. BMJ 1996: 313: 591-594.
9. SCHUNKERT H, HENSE HW, HOLMER SR, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994: 330: 1936-1938.
10. PEI Y, SCHOLEY J, THAI K, SUZUKI M, CATTAN D. Association of angiotensin gene T235 variant with progression of immunoglobulin a nephropathy in Caucasian patients. J Clin Invest 1997: 100: 814-820.
11. BROEKROELOFS J, STEGEMAN C, NAVIS G, TEGZESS AM, DE ZEEUW D, DE JONG PE. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism? J Am Soc Nephrol 1998: 9: 2075-2081.
12. ABDI R, TRAN TB, ZEE R, BRENNER BM, MILFORD EL. Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension. Transplantation 2001: 72: 726-729.
13. FILLER G, YANG F, MARTIN A, STOLPE J, NEUMAYER HH, HOCHER B. Renin angiotensin system gene polymorphism in pediatric renal transplant recipients. Pediatr Transplant 2001: 5: 166-173.
14. World health organization. Hypertension control: report of who expert committee. Geneva: World Health Organization, 1996.
15. Update on the Task force report on high blood pressure in children and adolescents: a working group report from national high blood pressure education program. National high blood pressure education program working group on hypertension control in children and adolescents. Pediatrics 1996: 98: 649-658.
16. SOERGEL M, KIRSCHSTEIN M, BUSCH C, et al. Osilometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997: 130: 178-184.
17. WUHL E, WITTE K, SOERGEL M, MEHLS O, SCHAEFER F, German working group on pediatric hypertension. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 2002: 20: 1995-2007.
18. RIGAT B, HUBERT C, CORVOL P, SOUBRIE F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) dipeptidyl carboxypeptidase 1. Nucleic Acids Res 1992: 20: 1433.
19. MORGAN H, KHAN HAN I, HASHMI A, HEBERT D, MCCRINDLE BW, BALFE JW. Ambulatory blood pressure monitoring after renal transplantation in children. Pediatr Nephrol 2001: 16: 843-847.
20. KOOMAN JP, CHRISTIAANS MHC, BOOTS JMM, VAN DER SANDE FM, LEUNISSEN KML, VAN HOOFF JP. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kid Dis 2001: 6: 1170-1176.
21. LINGENS N, DOBOS E, LEMMER B, SCHARER K. Nocturnal blood pressure elevation in transplanted pediatric patients. Kidney Int 1996: 55: S175-S176.
22. LINGENS N, DOBOS E, WITTE K, BUSCH C, LEMMER B, KLAUS G. Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 1997: 11: 23-26.
23. JACOBI J, ROCKSTROH J, JOHN S, et al. Prospective analysis of the value of 24-hour ambulatory blood pressure on renal function after kidney transplantation. Transplantation 2000: 70: 819-827.
24. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounts for half the variance of serum enzyme levels. J Clin Invest 1990: 86: 1343-1346.
25. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993: 290: 33-40.
26. FUJISAWA T, IKEGMA H, KAWAGUCHI Y, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 1988: 41: 47-53.
27. STRATTA P, CANAVESE C, CICCONE G, et al. Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population. Am J Kidney Dis 1999: 33: 1071-1079.
28. BABOOLAL K, RAVINE D, DANIELS J, et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of end stage renal failure in PKD1 adult polycystic kidney disease. Kidney Int 1997: 52: 607-613.
29. HOHENFELLNER K, HUNLEY TE, BREZINSKA R, et al. ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Pediatr Nephrol 1999: 13: 514-518.
30. BAROCCI S, GINERVI F, VALANTE U, TORRE F, GUSMANO R, NOCERA A. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney greft long-term outcome in pediatric recipients: a single center analysis. Transplantation 1999: 67: 534-538.